Skip to main content Skip to main navigation menu Skip to site footer

Pemberian ekstrak etanol Cordyceps militaris dapat menurunkan kadar glukosa darah dan menghambat penurunan massa sel beta pankreas pada tikus diabetes mellitus yang diinduksi dengan Streptozotocin dan Nikotinamid


Background: The antioxidant and anti-inflammatory effects of Cordyceps militaris extracts can neutralize the increased production of Reactive Oxygen Species (ROS) due to hyperglycemia conditions, as well as neutralize NO produced through inducible Nitric Oxide Synthase (iNOS). Thus, the antioxidant effects of C. militaris extract are expected to decrease DNA damage and ER stress leading to intrinsic apoptosis of pancreatic beta cells. Another positive effect of C. militaris which is expected to suppress glucotoxicity is its hypoglycemic effect.

Methods: The design of this study was Randomized Post-test Only Control Group Design. The study was conducted on mice divided into three groups: negative control group (DM + placebo), treatment 1 group and treatment 2 group.

Results: Based on study on 15 rats, each 5 rats per group, it was found that the mean blood glucose level in control group was 399,20 ± 28,07 mg/dl, mean of blood glucose level of treatment 1group  (extraction 50% ethanol Cordyceps militaris) was 198.60 ± 30.42 mg/dl, and, the mean blood glucose levels of the treatment 1 group  (extract ethanol Cordyceps militaris 100%) was 141.00 ± 17.03 mg/dl. With One Way ANOVA test found that p-value = 0,001. Immunohistochemical examination result shows that beta cell mass is more prominent in either treatment group 1 and treatment group 2 compare to the control group.

Conclusions: There were significant differences in blood glucose levels after extracted ethanol Cordyceps militaris. It is further known that ethanol extract of Cordyceps militaris can decrease blood glucose level by 50,25% at 50% concentration and 64,68% at 100% concentration. Immunohistochemical examination result shows that ethanol extract of C. militaris seem could inhibit the decrease of beta cell mass especially at 100% concentration.


  1. Aboderin, I., Kalache, A., Ben-Shlomo, Y., Lynch, J.W., Yajnik, C.S., Kuh, D., dan Yach, D. 2002. Life Course Perspective on Coronary Heart Disease, Stroke and Diabetes: The Evidence and Implications for Policy and Research. Geneva: WHO.
  2. Alberts, B., Johnson, A., Lewis, J., Morgan, D., Raff, M., Roberts, K. & Walter, P. 2015. Molecular Biology of The Cell, 6th Edition. New York: Garland Science.
  3. Ardies, C.M. 2014. Diet, Exercise and Chronic Disease. London: CRC Press.
  4. Arking, R. 2005. The Biology of Aging, 3rdEdition. New York: Oxford University Press. 9-11
  5. Arora, S. 2012. Molecular Basis of Insulin Resistance and Its Relation to Metabolic Syndrome. Dalam: Arora, S., editor. Insulin Resistance, 1st Ed. Croatia: InTech. p. 3-26.
  6. Biddinger, S. B. dan Emanuelli, B. 2011. Insulin Resistance in The Metabolic Syndrome. In: Ahima, R.S., editor. Metabolic Basis of Obesity, 1st Ed. USA: Springer. p. 175-198.
  7. Bonner-Weir, S., Li, W., Ouziel-Yahalom, L., Guo, L., Weir, G. C., & Sharma, A. 2010. β-Cell Growth and Regeneration: Replication Is Only Part of the Story. American Journal of Anatomy, 1911(12): 297-388.
  8. Buttler, A., Janson, J., Bonne- weir, S., Ritzel, R., Rizza, R., Buttler, P. 2003. β-Cell Deficit and Increased B-Cell Apoptosis in Humans With Type 2 Diabetes. Diabetes, 52: 102-110.
  9. Badan Pusat Statistik. 2006. Survei Ekonomi Nasional 2006 (SUSENAS 2006). BPS: Jakarta.
  10. Badan Pusat Statistik. 2013. Proyeksi Penduduk Indonesia 2010-2035. BPS: Jakarta.
  11. Byrd-Bredbenner, C., Moe, G., Beshgetoor, D., dan Berning, J. 2009. Wardlaw’s Presprectives in Nutrition. USA: McGraw Hill
  12. Cernea, S. & Dobreanu, M. 2013. Diabetes and Beta Cell Function: From Mechanisms to Evaluation and Clinical Implications. Biochemia Medica, 23(3): 266-280.
  13. Cersosimo, E. dan DeFronzo, R.A. 2006. Insulin Resistance and Endothelial Dysfunction: The Road Map to Cardiovascular Diseases. Diabetes, Metabolism Research and Reviews, 22(6): 423-436.
  14. Chandra, J., Zhivotovsky, B., Zaitsev, S., Juntti-Berggren, L., Olof Berggren, P., dan Orrenius, S. 2001. Role of Apoptosis in Pancreatic β-Cell Dealth in Diabetes. Diabetes, 50: 44-47.
  15. Chan, J. & Abrahamson, M. 2003. Pharmacological Management of Type 2 Mellitus: Rationale for Rational Use of Insulin. Mayo Clinic Proceedings, 78: 459-467.
  16. Choi, S., Park, C., Choi, M., Jun, D., dan Park, S . 2004. Improvement of Insulin Resistance and Insulin Secretion by Water Extracts of Cordyceps militaris, Phellinus linteus, and Paecilomyces tenuipes in 90 % Pancreatectomized. Bioscience, Biotechnology and Biochemistry, 68(11): 2257-2264.
  17. Choi, Y. H., Kim, G. Y., dan Lee, H. H. 2014. Anti-inflammatory Effects of Cordycepin in Lipopolysaccharide-stimulated RAW 264.7 Macrophages Through Toll-like receptor 4-mediated Suppression of Mitogen-activated Protein Kinases and NF-κB Signaling Pathways. Journal of Drug Design, Development and Therapy, 8: 1941-1953.
  18. Cnop, M., Welsh, N., Jonas, J., Joms, A., Lenzen, S., dan Eizirik, D. 2005. Mechanisms of Pancreatic β -Cell Death in Type 1 and Type2 Diabetes. Diabetes, 54: 97- 107.
  19. Cohen, A. dan Horton, E.S. 2007. Progress in The Treatment of Type 2 Diabetes, New Pharmacologic Approaches to Improve Glycemic Control. Current Medical Research and Opinion, 23 (4): 905-917.
  20. Das, S.K, Masuda, M., Sakurai, A. dan Sakakibara,M. 2010. Medicinal Uses of The Mushroom Cordyceps Militaris, Current State And Prospects. Elsevier Fitoterapia, 81: 961-968.
  21. Das, U. 2010. Metabolic Syndrome Pathophysiology The Role of Essential Fatty Acids. Iowa: Wiley-Blackwell.
  22. Donath, M. Y., Eshes, J. A., Maedler, K., Schumann, D. M., Ellingsgaard, H., Eppler, E., dan Reinecke. M. 2005. Mechanisms of β-Cell Death in Type 2 Diabetes. Diabetes, 54: l08-113.
  23. Federer, W. 2008. Statistics and Society: Data Collection and Interpretation, 2nd Edition. New York: Marcel Dekker.
  24. Fowler, B. 2003. Functional and Biological Markers of Aging. In: Klatz, R., editor. Anti-Aging Medical Therapeutics volume 5. Chicago: The A4M Publications. p. 43.
  25. Godoy-Matos, A. F. 2014. The Role of Glucagon on Type 2 Diabetes At a Glance. Diabetology & Metabolic Syndrome, 6: 91-95.
  26. Grankvist, K., Marklund, L. S., & Täljedal, I. 1981. Superoxide Dismutase is A Prophylactic Against Alloxan Diabetes. Nature, 294: 158-160.
  27. Gunasekaran, U & Gannon, M. 2011. Type 2 Diabetes and the Aging Pancreatic Beta Cell. Aging, 3(6): 565-575.
  28. Halliwell, B. dan Gutteridge, J. 2008. Free Radicals In Biology and Medicine, 4th Edition. New York: Oxford University Press.
  29. Higashi, Y. Noma, K., Yoshizumi, M., dan Kihara, Y. 2009. Endothelial Function and Oxidative Stres in Cardiovascular Diseases. Circulation Journal, 73, (4): 411-418.
  30. Hill, T., Krougly, O., Nikoopour, E., Bellemore, S., Lee-Chan, E., Fouser, L. A., Hill, D. J. & Singh, B. 2013. The Involvement of Interleukin-22 in The Expression of Pancreatic Beta Cell Regenerative Reg Genes.
  31. Ho, E., Galougahi, K. K., Liu, C., Bhindi, R., & Figtree, G. A. 2013. Biological Markers of Oxidative Stres: Applications to Cardiovascular Research and Practice. Redox Biology, 1: 483-491.
  32. Hohmeier, H. E., Thigpen, A., Tran, V. V., Davis, R., & Newgard, C. B. 1998. Stable Expression of Manganese Superoxide Dismutase (MnSOD) in Insulinoma Cells Prevents IL-1b–induced Cytotoxicity and Reduces Nitric Oxide Production. Journal of Clinical Investigation, 101(9): 1811-1820.
  33. Holman, R. R. 1998. Assessing The Potential for Alpha-Glucosidase Inhibitors in Prediabetic States. Diabetes Research and Clinical Practice, 40: 21-25.
  34. Huang, C., Lin, C. Y., Haataja, L., Gurlo, T., Butler, A. E., Rizza, R. A., dan Butler, P. C. 2007. High Expression Rates of Human Islet Amyloid Polypeptide Induce Endoplasmic Reticulum Stres-Mediated β-Cell Apoptosis.a Characteristic of Humans With Type 2 Not Type 1 Diabetes. Diabetes, 56: 2016-2017.
  35. Hunt, J. V., Dean, R. T., & Wolff, S. P. 1988. Hydroxyl Radical Production and Atoxidative Glycosylation Glucose Autoxidation as The Cause of Protein Damage in The Experimental Glycation Model of Diabetes Mellitus and Ageing. Biochemical Journal, 256: 205-212.
  36. Hyman, M. 2009. System Biology, Toxins, Obesity, and Functional Medicine. Available at: (Accessed: November 20th, 2014).
  37. Jones, D. S. dan Bland, S. Q. 2010. What is Functional Medicine?. Dalam: Jones, D. S., editor. Textbook of Functional Medicine, 3rd Edition. USA: The Institue of Functional Medicine. p. , 5-14.
  38. Kachakhidze, D. 2011. World Life Expectancy and Future Longevity Scenarios. France: Gilles Meyer.
  39. Kahn, S., Hull, R. & Utzschneider, K., 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444.
  40. Khalaileh, A., Gonen-Gross, T., Magenheim, J., Nir, T., Porat, S., Salpeter, S., Stolovich-Rain, M., Swisa, A., Weinberg, N. & Dor, Y. 2008. Determinants of Pancreatic B-cell Regeneration. Diabetes, Obesity and Metabolism, 10(4): 128-135.
  41. Klatz, R. dan Goldman, R. 2012. Perspective in Anti-Aging & Regenerative Medicine, State of The Specialty Report: Anti-Aging Medicine at Twenty Years (2012). In: Klatz, R. & Goldman, R., editors. Encyclopedia of Clinical Anti-Aging Medicine & Regenerative Biomedical Technologies, 1st Ed. USA: The American Academy of Anti-Aging Medicine. p. 1-9.
  42. Kubisch, H. M., Wang, J., Lunche, R., Carlson, E., Bray, T. M., Epstein, C. J., & Philips, J. P. 1994. Transgenic Copper/Zinc Superoxide Dismutase Modulates Susceptibility to Type I Diabetes. Proceeding of the Natural Academy of Sciences, 91: 9956-9959.
  43. Leonardi, O., Mints, G. dan Hussain, M., 2003. Beta-cell apoptosis in the Pathogenesis of Human Type 2 Diabetes Mellitus. European Journal of Endocrinology, 149: 99-102.
  44. Li, S. P., Zhang, G. H., Zeng, Q., Huang, Z. G., Wang, Y. T., Dong, T. T. X., & Tsim, K. W. K. 2006. Hypoglycemic Activity of Polysaccharide, with Antioxidation, Isolated from Cultured Cordyceps Mycelia. Phytomedicine, 13: 428–433
  45. Liu, B., Chen, Y., & St. Clair, D. K. 2008. ROS and p53: A Versatile Partnership. Free Radical Biology and Medicine, 44(8): 1529-1535.
  46. Lortz, S., Tiedge, M., Nachtwey, T., Karlsen, A. E., Nerup, J., & Lenzen, S. 2000. Protection of Insulin-Producing RINm5F Cells Against Cytokine-Mediated Toxicity Through Overexpression of Antioxidant Enzymes. Diabetes, 49: 1123-1130.
  47. Lunenfeld, B., Gooren, L. J. G., Morales, A., dan Morley, J. E. 2007. Textbook of Men’s Health and Aging. UK: Informa.
  48. Ma, L., Zhang, S., & Du, M. 2015. Cordycepin From Cordyceps militaris Prevents Hyperglycemia in Alloxan-induced Diabetic Mice. Nutrition Research, 35(5): 431-439.
  49. Machin, D dan Campbell, MJ. 2005. Design of Studies for Medical Research. John Wiley & Sons, Chichester.
  50. Matveyenko, A. V. dan Butler, P. C. 2008. Relationship Between β-Cell Mass and Diabetes Onset. Diabetes, Obesity and Metabolism, 10(4): 23-31.
  51. McCance, K.L. dan Grey, T.C 2006. Altered Cellular and Tissue Biology. In: McCane, K. L., & Huether, S. E., editors. Patophysiology, 5th Ed. Canada: Elsevier Mosby. p. 82-86.
  52. Morioka, T. dan Kulkarni, R. N. 2011. Pancreatic Islet β-Cell Failure in Obesity. In: Ahima, R. S., editor. Metabolic Basis of Obesity, 1st Ed. USA: Springer. p. 199-217.
  53. Moriscot, C., Pattou, E., Kerr-Conte, J., Richard, M. J., Lemarchand, P., & Benhamou, P. Y. 2000. Contribution of Adenoviral-mediated Superoxide Dismutase Gene Transfer to The Reduction in Nitric Oxide-induced Cytotoxicity on Human Islets and INS-1 Insulin-secreting Cells. Diabetologia, 43: 625-631.
  54. Mudaliar, S. 2007. New Frontier in Management of Type 2 Diabetes. Indian Journal of Medical Research, 125(3): 275-296.
  55. National Institute of Aging. 2011. Global Health and Aging. USA: National Institute of Aging.
  56. Pangkahila, W. 2007. Anti-aging Medicine: Memperlambat Penuaan, Meningkatkan Kualitas Hidup. Kompas: Jakarta.
  57. Paterson, R., 2008. Cordyceps - A traditional Chinese Medicine and Another Fungal Therapeutic Biofactory. Elsevier Phytochemistry, 69: 1469-1495.
  58. Potteiger, J.A. 2011. ACSM’s Introduction to Exercise Science. USA: Lippincott Williams & Wilkins.
  59. Powers, A. C. 2008. Diabetes Mellitus. In: Fauci, A. S., Braunwald, E., Kasper, D. L., Hauser, S. L., Longo, D. L., & Jameson J. L., editors. Harrison’s Principles of Internal Medicine, 17th Ed. New York: McGraw Hill. p. 2275-2304.
  60. Nahas, R. 2012. Type 2 Diabetes. In: Rakel, D., editor. Integrative Medicine, 3rd Ed. USA: Elsevier. p. 297-311.
  61. Popa, S & Mota, M. 2013. Beta-Cell Function and Failure in Type 2 Diabetes. Dalam: Masuo, K., editor. Type 2 Diabetes, 1st Ed. Croatia: Intech. p. 29-50.
  62. Rao, Y., Fang, S. H., Wu, W. S., dan Tzeng, Y. M. 2010. Constituents Isolated From Cordyceps Militaris Suppress Enhanced Inflammatory Mediator's Production. Elsevier- Ethnophrarmacology, 131: 363-367.
  63. Rhodes, C. 2005. Type 2 Diabetes-A Matter of β-Cell Life Death?. Science, 307: 380-383.
  64. Robertson, B. P., Harmon, J., Tran, P. O., Tanaka, Y., & Takahashi, H. 2003. Glucose Toxicity in β-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and The Glutathione Connection. Diabetes, 52: 581-587.
  65. Salgado, A. L. F. A., Carvalho, L., Oliveira A. C., Santos V. N., Vieira, J. G., & Parise E. R. 2010. Insulin Resistance Index (HOMA-IR) in The Differentiation of Patients with Non-Alcoholic Fatty Liver Disease and Healthy Individuals. Arquivos De Gastroenterologia, 47(2): 165-169.
  66. Shin, S., Lee, S., Kwon, J., Moon, S., Lee, S., Lee, C., Cho, K., Ha, N., & Kim, K. 2009. Cordycepin Suppresses Expression of Diabetes Regulating Genes by Inhibition of Lipopolysaccharide-induced Inflammation in Macrophages. Immune Network, 9(3): 98-105.
  67. Skyler, J. S. 2012. Atlas of Diabetes. 4th ed. New York: Springer.
  68. Stanner, S., Thompson, R., & Buttriss, J. 2009. Healthy Ageing: The Role Of Nutrition and Lifestyle. UK: Wiley-Blackwell.
  69. Suastika, K., Dwipayana, P., Semadi, M. S., & Kuswardhani, R. A. T. 2012. Age is an Important Risk Factor For Type 2 Diabetes Mellitus and Cardiovascular Diseases. In: Chackrewarthy, S., editor. Glucose Tolerance. Croatia: Intech. p. 67-80.
  70. Szkudelski, T. 2012. Streptozotocin-nicotinamide-induced Diabetes in The Rat: Characteristics of The Experimental Model. Experimental Biology and Medicine, 237: 481-490.
  71. Tan, K.C.B., Chow, W. S., Ai, V. H. G., Metz, C., Bucala, R., & Lam, K. S. L. 2002. Advanced Glycation End Products and Endothelial Dysfunction in Type 2 Diabetes. Diabetes Care, 25: 1055-1059.
  72. Tanaka, Y., Tran, P .O. T., Harmon, J., & Robertson, R. P. 2002. A Role for Glutathione Peroxidase in Protecting Pancreatic β-Cells Against Oxidative Stress in A Model of Glucose Toxicity. PNAS, 99 (19): 12363-12368.
  73. Tiedge, M., Lortz, S., Munday, R., & Lenzen, S. 1999. Protection Against The Co-operative Toxicity of Nitric Oxide and Oxygen Free Radicals by Overexpression of Antioxidant Enzymes in Bioengineered Insulin-producing RINm5F Cells. Diabetologia, 42: 849-855.
  74. Torres-Leal, F. L., Fonseca-Alanis, M. H., de Oliveira, A. C., & Alonso-Vale, M. I. C. 2012. Adipose Tissue Inflammation and Insulin Resistance. Dalam: Arora, S., editor. Insulin Resistance, 1st Ed. Croatia: InTech. p. 137-156.
  75. Trindade, F. 2012. The Continuum of Insulin Resistance. Dalam: Klatz, R. & Goldman, R., editor. Encyclopedia of Clinical Anti-Aging Medicine & Regenerative Biomedical Technologies, 1st Ed. USA: The American Academy of Anti-Aging Medicine. p. 1-9.
  76. Wali, A. J., Masters, S. L., dan Thomas, H. E. 2013. Linking Metabolic Abnormalities to Apoptotic Pathways in Beta Cells in Type 2 Diabetes. Cells, 2: 266-283.
  77. WHO. 2002. Active Aging: A Policy Framework. (Online) (Available from:, Accessed: August, 20th 2014)
  78. WHO. 2008. Physical Activity. (Online) (Available from: actsheets/fs385/en/, Accessed: August, 20th 2014).
  79. WHO. 2015. World Health Statistics 2015. WHO: Luxemburg.
  80. WHO. 2016. Global Report On Diabetes. WHO: France.
  81. Wikana, J. 2014. Pemberian Ekstraks Etanol C. Militaris Dapat Menurunkan Kadar Glukosa Darah dan Mempertahankan Massa Sel Beta Pankreas PadaTikus Diabetes Mellitus Tipe 2. Penelitian Pendahuluan.
  82. WiId, S., Roglic, G., Green, A., Sicree, R., & King, H. 2004. Global Prevalenceof Diabetes: Estimates for The Year 2000 and Projections for 2030. Diabetes Care, 27(5): 1047-1053.
  83. Wali, J. A., Masters, S. L., & Thomas, H. E. 2013. Linking Metabolic Abnormalities to Apoptotic Pathways in Beta Cells in Type 2 Diabetes. Cells, 2: 266-283.
  84. Wallace, T. M., Levy, J. C., & Matthews D. R. 2004. Use and Abuse of HOMA Modeling. Diabetes Care, 27(6): 1487-1495.
  85. Wolff, S. P. & Dean, R. T. 1987. Glucose Autoxidation and Protein Modification: The Role of “Autoxidative Glycosilation†in Diabetes. Biochemical Journal, 245: 243-250.
  86. Won, S. & Park, E., 2004. Anti-inflammatory and Related Pharmacological Activities of Cultured Mycelia and Fruiting Bodies of CordycepsMilitaris. Journal of Ethnopharmacology, 96: 555-561.
  87. Yang, H. & Li, X. 2012. The Role of Fatty Acid Metabolism and Lipotoxicity in Pancreatic β-Cell Injury: Identification of Potential Therapeutic Targets. Acta Pharmaceutica Sinica B, 2(4): 396-402.
  88. Yount, WR. 2006. Research Design & Statistical Analysis in Christian Ministry 4th Edition. Printed in the USA.
  89. Yun, Y., Han, S., Lee, S., Ko, S. K., Lee, C., Ha, N., & Kim, K. 2003. Anti-diabetic Effects of CCCA, CMESS, and Cordycepin from Cordyceps militaris and the Immune Responses in Streptozotocin-induced Diabetic Mice. Natural Product Science, 9(4): 291-298.
  90. Zhang, G.,Huang, Y., Bian, Y., Wong, J., & Wang, H, 2006. Hypoglycemic activity of Cordyceps militaris, Cordyceps senensis, Tricholoma mongolicum, and Omphalia lapidescens in Streptozotocin-induced Diabetic Rats. Biotechnological Produstcs And Process Engineering, 72: 1152-1156.

How to Cite

Wikana, J. (2018). Pemberian ekstrak etanol Cordyceps militaris dapat menurunkan kadar glukosa darah dan menghambat penurunan massa sel beta pankreas pada tikus diabetes mellitus yang diinduksi dengan Streptozotocin dan Nikotinamid. Intisari Sains Medis, 9(2).




Search Panel